SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
sslou
Lv1
50 积分
2022-09-21 加入
最近求助
最近应助
互助留言
Controlled Fab-arm exchange for the generation of stable bispecific IgG1
3天前
已完结
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
6天前
已完结
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling
18天前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
21天前
已完结
Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices
1个月前
已完结
Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices
1个月前
已完结
Preclinical studies of the bispecific MUC1xEGFR antibody drug conjugate M1231 in EGFR mutant NSCLC
3个月前
已完结
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
4个月前
已完结
A PTK7-targeted antibody-drug conjugate reduces
4个月前
已关闭
Preclinical Characterization of Catabolic Pathways and Metabolism of ABBV-011, a Novel Calicheamicin-Based SEZ6-Targeting Antibody-Drug Conjugate
4个月前
已完结
没有进行任何应助
速度真快
3天前
感谢
6天前
感谢
18天前
速度真快
21天前
感谢
1个月前
感谢
1个月前
感谢
3个月前
感谢
4个月前
输入错误【积分已退回】
4个月前
速度真快
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论